HOME > 상세정보

상세정보

Controversies in the management of gynecological cancers [electronic resource]

Controversies in the management of gynecological cancers [electronic resource]

자료유형
E-Book(소장)
개인저자
Ledermann, Jonathan A. Creutzberg, Carien L. Quinn, Michael A.
서명 / 저자사항
Controversies in the management of gynecological cancers [electronic resource] / Jonathan A. Ledermann, Carien L. Creutzberg, Michael A. Quinn, editors.
발행사항
London :   Springer London :   Imprint: Springer,   2014.  
형태사항
1 online resource (xv, 349 p.) : ill. (some col.).
ISBN
9780857299109
요약
Gynecological cancers are some of the most commonly occurring malignancies in women. Despite their high incidence, treatment and management of these cancers remain controversial, with conflicting evidence about  many aspects of the disease.   Controversies in the Management of Gynecological Cancers offers a unique assessment of the opposing sides of the controversial issues associated with gynecological cancers, and aims to provide professionals in the field with a keener sense of the underlying evidence-base and a starting point from which to follow the ongoing debate. A section on the direction of future research to resolve these issues completes the discussion in each chapter.   This book will appeal to specialists, trainees and healthcare workers in gynecological oncology, gynecologists, medical oncologists and radiation oncologists, and is an excellent starting point for anyone who wishes to gain a better understanding of the complex nature of the management of gynecological malignancy.  
일반주기
Title from e-Book title page.  
내용주기
1. Controversies in the Treatment of Women with Early Stage Epithelial Ovarian Cancer -- 2. Recurrent Ovarian Cancer: When to Treat and How to Assess -- 3. New Views of Ovarian Carcinoma Types: How will this Change Practice? -- 4. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated -- 5. What is the Role of Adjuvant Radiotherapy and Chemotherapy in Endometrial Cancer? -- 6. Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink? -- 7. Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries -- 8. What is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer? -- 9. Response as a Measure of Treatment Efficacy in Clinical Trials:  Should RECIST Be Abandoned? -- 10. What are the Treatment Options for Recurrent Ovarian Cancer? -- 11. How To Study Rare Gynaecological Tumours: Trials or Registries? -- 12. What is the Best Treatment Model for Gynaecological Cancers? Does Centralization Help? -- 13. When Should Surgery be Performed for the First-Line Treatment of Advanced Ovarian Cancer? -- 14. Does Intraperitoneal Therapy for Ovarian Cancer have a Future? -- 15. Maintenance Therapy for First-Line Treatment of Ovarian Cancer—Is this the Strategy for the Future? -- 16. What is the Value of Lymphadenectomy in Early Ovarian Cancer? -- 17. Sentinel Node Biopsy—Does it Help in the Management of Vulvar Cancer? -- 18. Controversies in the Management of Advanced Vulvar Cancer -- 19. Bowel Obstruction in Ovarian Cancer: To Operate or Not? -- 20. Early Cervical Cancer: Can Fertility be Safely Preserved? -- 21. What is the Role of PET/CT in Gynaecologic Cancers? -- 22. Do Intensity-Modulated Radiation, Image-Guided Radiation, and 3D Brachytherapy Significantly Advance Radiotherapeutic Management of Gynecologic Cancers? -- 23. What is the Place of Hormone Replacement Therapy in Ovarian, Endometrial, and Breast Cancer? -- 24. Familial Gynaecological Cancers: Whom to Screen and How to Manage? -- 25. Trial Design: Should Randomized Phase III Trials in Gynaecological Cancers be Abandoned? -- 26. How Should Early Gestational Trophoblastic Disease be Managed? -- 27. Should Every Woman with Gynaecologic Cancer Undergo Routine Screening for Psychological Distress and Sexual Dysfunction? -- 28. How Should Gynaecological Sarcomas be Managed? -- 29. What is the Future of Immunotherapy in Ovarian Cancer?.
서지주기
Includes bibliographical references and index.
이용가능한 다른형태자료
Issued also as a book.  
일반주제명
Generative organs, Female --Cancer --Treatment.
바로가기
URL
000 00000nam u2200205 a 4500
001 000046041799
005 20200825132917
006 m d
007 cr
008 200814s2014 enka ob 001 0 eng d
020 ▼a 9780857299109
040 ▼a 211009 ▼c 211009 ▼d 211009
050 4 ▼a RC254-282
082 0 4 ▼a 616.9946506 ▼2 23
084 ▼a 616.9946506 ▼2 DDCK
090 ▼a 616.9946506
245 0 0 ▼a Controversies in the management of gynecological cancers ▼h [electronic resource] / ▼c Jonathan A. Ledermann, Carien L. Creutzberg, Michael A. Quinn, editors.
260 ▼a London : ▼b Springer London : ▼b Imprint: Springer, ▼c 2014.
300 ▼a 1 online resource (xv, 349 p.) : ▼b ill. (some col.).
500 ▼a Title from e-Book title page.
504 ▼a Includes bibliographical references and index.
505 0 ▼a 1. Controversies in the Treatment of Women with Early Stage Epithelial Ovarian Cancer -- 2. Recurrent Ovarian Cancer: When to Treat and How to Assess -- 3. New Views of Ovarian Carcinoma Types: How will this Change Practice? -- 4. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated -- 5. What is the Role of Adjuvant Radiotherapy and Chemotherapy in Endometrial Cancer? -- 6. Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink? -- 7. Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries -- 8. What is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer? -- 9. Response as a Measure of Treatment Efficacy in Clinical Trials:  Should RECIST Be Abandoned? -- 10. What are the Treatment Options for Recurrent Ovarian Cancer? -- 11. How To Study Rare Gynaecological Tumours: Trials or Registries? -- 12. What is the Best Treatment Model for Gynaecological Cancers? Does Centralization Help? -- 13. When Should Surgery be Performed for the First-Line Treatment of Advanced Ovarian Cancer? -- 14. Does Intraperitoneal Therapy for Ovarian Cancer have a Future? -- 15. Maintenance Therapy for First-Line Treatment of Ovarian Cancer—Is this the Strategy for the Future? -- 16. What is the Value of Lymphadenectomy in Early Ovarian Cancer? -- 17. Sentinel Node Biopsy—Does it Help in the Management of Vulvar Cancer? -- 18. Controversies in the Management of Advanced Vulvar Cancer -- 19. Bowel Obstruction in Ovarian Cancer: To Operate or Not? -- 20. Early Cervical Cancer: Can Fertility be Safely Preserved? -- 21. What is the Role of PET/CT in Gynaecologic Cancers? -- 22. Do Intensity-Modulated Radiation, Image-Guided Radiation, and 3D Brachytherapy Significantly Advance Radiotherapeutic Management of Gynecologic Cancers? -- 23. What is the Place of Hormone Replacement Therapy in Ovarian, Endometrial, and Breast Cancer? -- 24. Familial Gynaecological Cancers: Whom to Screen and How to Manage? -- 25. Trial Design: Should Randomized Phase III Trials in Gynaecological Cancers be Abandoned? -- 26. How Should Early Gestational Trophoblastic Disease be Managed? -- 27. Should Every Woman with Gynaecologic Cancer Undergo Routine Screening for Psychological Distress and Sexual Dysfunction? -- 28. How Should Gynaecological Sarcomas be Managed? -- 29. What is the Future of Immunotherapy in Ovarian Cancer?.
520 ▼a Gynecological cancers are some of the most commonly occurring malignancies in women. Despite their high incidence, treatment and management of these cancers remain controversial, with conflicting evidence about  many aspects of the disease.   Controversies in the Management of Gynecological Cancers offers a unique assessment of the opposing sides of the controversial issues associated with gynecological cancers, and aims to provide professionals in the field with a keener sense of the underlying evidence-base and a starting point from which to follow the ongoing debate. A section on the direction of future research to resolve these issues completes the discussion in each chapter.   This book will appeal to specialists, trainees and healthcare workers in gynecological oncology, gynecologists, medical oncologists and radiation oncologists, and is an excellent starting point for anyone who wishes to gain a better understanding of the complex nature of the management of gynecological malignancy.  
530 ▼a Issued also as a book.
538 ▼a Mode of access: World Wide Web.
650 0 ▼a Generative organs, Female ▼x Cancer ▼x Treatment.
700 1 ▼a Ledermann, Jonathan A.
700 1 ▼a Creutzberg, Carien L.
700 1 ▼a Quinn, Michael A.
856 4 0 ▼u https://oca.korea.ac.kr/link.n2s?url=http://dx.doi.org/10.1007/978-0-85729-910-9
945 ▼a KLPA
991 ▼a E-Book(소장)

소장정보

No. 소장처 청구기호 등록번호 도서상태 반납예정일 예약 서비스
No. 1 소장처 중앙도서관/e-Book 컬렉션/ 청구기호 CR 616.9946506 등록번호 E14030516 도서상태 대출불가(열람가능) 반납예정일 예약 서비스 M

관련분야 신착자료

대한배뇨장애요실금학회 (2021)
Amin, Mahul B. (2021)
Louis, Elan D (2022)
Church, Dawson (2020)